Q4 2018 EPS Estimates for Illumina, Inc. Lifted by Analyst (ILMN)

Illumina, Inc. (NASDAQ:ILMN) – Analysts at William Blair raised their Q4 2018 earnings estimates for Illumina in a research note issued to investors on Tuesday. William Blair analyst A. Murphy now expects that the life sciences company will earn $1.25 per share for the quarter, up from their prior estimate of $1.24. William Blair currently has a “Market Perform” rating on the stock.

Illumina (NASDAQ:ILMN) last announced its quarterly earnings data on Tuesday, January 30th. The life sciences company reported $1.44 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.22 by $0.22. The business had revenue of $778.00 million during the quarter, compared to analysts’ expectations of $752.04 million. Illumina had a return on equity of 21.52% and a net margin of 26.56%. The firm’s quarterly revenue was up 25.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.85 earnings per share.

A number of other research analysts have also recently issued reports on the company. Wells Fargo & Co upgraded Illumina from a “market perform” rating to an “outperform” rating and set a $205.00 price objective for the company in a research note on Tuesday, January 2nd. Morgan Stanley lifted their price objective on Illumina from $122.00 to $135.00 and gave the company an “underweight” rating in a research note on Thursday, December 14th. Citigroup lifted their price objective on Illumina from $180.00 to $220.00 and gave the company a “neutral” rating in a research note on Wednesday, October 25th. Zacks Investment Research upgraded Illumina from a “hold” rating to a “buy” rating and set a $252.00 price objective for the company in a research note on Tuesday, December 5th. Finally, Piper Jaffray Companies reiterated a “buy” rating and set a $269.00 price objective on shares of Illumina in a research note on Tuesday, January 9th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the stock. Illumina has an average rating of “Buy” and a consensus price target of $241.39.

Shares of Illumina (NASDAQ:ILMN) traded up $1.30 during trading hours on Wednesday, reaching $221.74. The company’s stock had a trading volume of 354,452 shares, compared to its average volume of 1,065,865. The stock has a market capitalization of $32,260.00, a PE ratio of 44.98, a price-to-earnings-growth ratio of 2.92 and a beta of 0.92. Illumina has a 1-year low of $158.02 and a 1-year high of $248.97. The company has a quick ratio of 3.55, a current ratio of 3.99 and a debt-to-equity ratio of 0.42.

Institutional investors have recently bought and sold shares of the stock. Financial Gravity Companies Inc. purchased a new stake in Illumina during the fourth quarter valued at $106,000. SeaCrest Wealth Management LLC purchased a new stake in Illumina during the fourth quarter valued at $154,000. Dupont Capital Management Corp purchased a new stake in Illumina during the third quarter valued at $153,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its position in Illumina by 113.9% during the fourth quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 770 shares of the life sciences company’s stock valued at $168,000 after acquiring an additional 410 shares during the last quarter. Finally, Advisory Services Network LLC increased its position in Illumina by 13.0% during the second quarter. Advisory Services Network LLC now owns 772 shares of the life sciences company’s stock valued at $134,000 after acquiring an additional 89 shares during the last quarter. Institutional investors own 92.04% of the company’s stock.

In related news, SVP Charles Dadswell sold 145 shares of the company’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $225.33, for a total transaction of $32,672.85. Following the completion of the sale, the senior vice president now owns 6,388 shares in the company, valued at $1,439,408.04. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Marc Stapley sold 2,000 shares of the company’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $216.87, for a total value of $433,740.00. Following the sale, the executive vice president now owns 27,952 shares of the company’s stock, valued at approximately $6,061,950.24. The disclosure for this sale can be found here. Insiders sold 114,440 shares of company stock valued at $25,318,904 in the last 90 days. Company insiders own 0.89% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Q4 2018 EPS Estimates for Illumina, Inc. Lifted by Analyst (ILMN)” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/14/q4-2018-eps-estimates-for-illumina-inc-lifted-by-analyst-ilmn.html.

Illumina Company Profile

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

Earnings History and Estimates for Illumina (NASDAQ:ILMN)

Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply